2017-03-01,Lilly Completes Acquisition Of CoLucid Pharmaceuticals
2017-02-02,INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of CoLucid Pharmaceuticals, Inc. To Eli Lilly & Co. For $46.50 Per Share Is Fair To Shareholders
2017-01-31,Bragar Eagel & Squire, P.C. Is Investigating The Board Of Directors Of CoLucid Pharmaceuticals, Inc. (CLCD) On Behalf Of Stockholders And Encourages Investors To Contact The Firm
2017-01-31,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Into Whether The Sale Of CoLucid Pharmaceuticals, Inc. To Eli Lilly & Co. For $46.50 Per Share Is Fair To Shareholders -- CLCD
2017-01-30,INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
2017-01-27,INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Whether The Sale Of CoLucid Pharmaceuticals, Inc. To Eli Lilly & Co. For $46.50 Per Share Is Fair To Shareholders -- CLCD
2017-01-23,SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
2017-01-20,SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces An Investigation Of The Board Of Directors Of CoLucid Pharmaceuticals, Inc. -CLCD
2017-01-20,COLUCID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of CoLucid Pharmaceuticals, Inc. (CLCD) Over The Proposed Sale Of The Company To Eli Lilly And Company
2017-01-19,Robbins Arroyo LLP: Acquisition Of CoLucid Pharmaceuticals, Inc. (CLCD) By Eli Lilly And Company (LLY) May Not Be In Shareholders' Best Interests
2017-01-19,CoLucid Pharmaceuticals Reaches Analyst Target Price
2017-01-18,Harwood Feffer LLP Announces Investigation Of CoLucid Pharmaceuticals, Inc.
2017-01-18,Stocks Hold Mixed as Fed's Yellen Forecasts Series of Rate Hikes
2017-01-18,Must-Know Tricks On Trading Goldman Sachs, Ford and Other Very Active Stocks
2017-01-18,COLUCID PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By Eli Lilly And Company May Be Unfair To Shareholders
2017-01-18,COLUCID PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
2017-01-18,Stocks Struggle for Direction as Economic Improvements May Push Fed Moves
2017-01-18,Stock Futures Inch Higher as Citigroup, Goldman Sachs Get Trading Boost
2017-01-18,Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
2017-01-18,CoLucid (CLCD) Alert: Johnson & Weaver, LLP Launches An Investigation Into The Fairness Of Price And Process In Proposed Sale Of CoLucid Pharmaceuticals, Inc.; Is $46.50 A Fair Price?
2017-01-18,Eli Lilly Acquires CoLucid Pharma, Adds Migraine Drug to Pipeline
2017-01-18,Lilly And CoLucid Pharmaceuticals Announce Agreement For Lilly To Acquire CoLucid
2016-11-28,CoLucid Pharmaceuticals To Present At The 28th Annual Piper Jaffray Healthcare Conference
2016-11-15,Airline Stocks Get Airborne
2016-11-14,CoLucid Pharmaceuticals Provides SPARTAN Enrollment Update
2016-11-09,CoLucid Pharmaceuticals Announces 2016 Third Quarter Results And Corporate Highlights
2016-11-08,CoLucid Pharmaceuticals To Present At The Stifel 2016 Healthcare Conference
2016-10-20,Why These 4 Little-Known Stocks Have Outgunned the DJIA This Year
2016-10-05,CoLucid Pharmaceuticals Announces Additional Analyses Of Lasmiditan's Onset Of Action Data From SAMURAI And Supporting Non-Clinical Data
2016-09-29,4 Stocks with Strong Technicals to Buy Now
2016-09-26,CoLucid Pharmaceuticals To Present At The Ladenburg Thalmann 2016 Healthcare Conference
2016-09-19,CORRECTING And REPLACING - CoLucid Pharmaceuticals Provides Interim Update On GLADIATOR
2016-09-19,CoLucid Pharmaceuticals Provides Interim Update On GLADIATOR
2016-09-17,CoLucid Pharmaceuticals Announces Achievement Of Secondary Endpoints In SAMURAI
2016-09-09,Here's a Reason Why CoLucid Pharmaceuticals (CLCD) Stock Is Higher Today
2016-09-09,CoLucid Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2016-09-08,CoLucid Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2016-09-07,CoLucid Pharmaceuticals Reaches Analyst Target Price
2016-09-06,CoLucid Pharmaceuticals (CLCD) Stock Skyrockets on Migraine Drug Trial Success
2016-09-06,CoLucid Pharmaceuticals Announces Achievement Of Both Primary And Key Secondary Endpoints In The SAMURAI Phase 3 Pivotal Trial Of Lasmiditan In Migraine
2016-08-26,These 5 Stocks Are Breaking Out
2016-08-18,King Fish Media Announces Website Launch For CoLucid Pharmaceuticals
2016-08-10,CoLucid Pharmaceuticals Announces 2016 Second Quarter Results And Corporate Highlights
2016-06-22,CoLucid Pharmaceuticals Hosting Key Opinion Leader Meeting In New York City
2016-06-07,CoLucid Pharmaceuticals Announces Last Patient Randomized In SAMURAI Phase 3 Pivotal Trial Of Lasmiditan In Migraine
2016-06-02,CoLucid Pharmaceuticals To Participate At The Jefferies 2016 Healthcare Conference
2016-05-19,CoLucid Pharmaceuticals Announces Initiation Of Second Phase 3 Pivotal Trial Of Lasmiditan In Migraine
2016-05-11,CoLucid Pharmaceuticals Announces 2016 First Quarter Results And Corporate Highlights
2016-03-15,CoLucid Pharmaceuticals Announces Election Of Alison Lawton To Board Of Directors
2016-03-03,CoLucid Pharmaceuticals To Present Corporate Overview At The Cowen & Company 36th Annual Health Care Conference
2016-03-02,CoLucid Pharmaceuticals Announces 2015 Fourth Quarter And Year-End Results And Corporate Highlights
2016-03-01,CoLucid Pharmaceuticals Announces Special Protocol Agreement For SPARTAN
2016-02-23,CoLucid Pharmaceuticals Announces Confirmatory Support For Non-vasoconstrictive Mechanism Of Action For Lasmiditan
2016-02-02,CoLucid Pharmaceuticals To Present Corporate Overview At The BIO CEO & Investor Conference
2016-01-05,CoLucid Pharmaceuticals And IMS Health Publish White Paper To Address Migraine Market Misperceptions
2015-12-08,CoLucid Pharmaceuticals Announces Appointment Of Dr. Raymond Skwierczynski As Head, Pharmaceutical Operations
2015-11-30,CoLucid Pharmaceuticals Provides SAMURAI Enrollment Update
2015-11-12,CoLucid Pharmaceuticals To Present Corporate Overview At The Stifel 2015 Healthcare Conference
2015-11-10,CoLucid Pharmaceuticals Announces Third Quarter 2015 Results And Corporate Highlights
2015-10-27,CoLucid Pharmaceuticals Announces Election Of Mark Corrigan, M.D., To Board Of Directors
2015-10-08,CoLucid Pharmaceuticals Announces Initiation Of Phase 3 Long-Term, Open-Label Trial Of Lasmiditan In Migraine
2015-09-03,CoLucid Pharmaceuticals To Present At Two Investor Conferences In September
2015-08-12,CoLucid Pharmaceuticals Announces Second Quarter 2015 Results And Corporate Highlights
2015-07-13,CoLucid Pharmaceuticals Announces Appointment Of Marvin L. White To Board Of Directors
2015-05-06,CoLucid Pharmaceuticals Announces Pricing Of Initial Public Offering
,
,
,
